Latest Biotech News

10x Genomics unveiled its Atera spatial platform at AACR 2026, pitching whole-transcriptome spatial biology at higher throughput and plex than its prior Xenium system. The company said Atera...

Researchers reported that adenine base editing (ABE) can rescue a cryptic splice mutation tied to cardiac-type Fabry disease in cells. The work, published in Gene Therapy, targets a specific G>A...

STAT+ highlighted how the search for durable KRAS-mutant therapies has accelerated since early KRAS drugs fell short on response durability. The report centers on Revolution Medicines’...

A Nature Communications study reported that wastewater-based epidemiology can detect the emergence of clinically significant, drug-resistant Candida auris in healthcare settings. Researchers used...

Grey Wolf Therapeutics appointed serial entrepreneur Edwin Moses as chair, while Harbour BioMed (HBM Holdings) hired Adam Zong as president. Moses’ background includes leadership roles across UK...

A BIOCENTURY report said the FDA’s budget proposal includes a policy wish list that would make pediatric priority review vouchers permanent and would reduce industry participation on advisory...

CSPI criticized the FDA’s plans to convene a Pharmacy Compounding Advisory Committee meeting in July to consider adding seven injectable peptides to what can be compounded. The statement argues...

The NSF awarded a record 2,599 Graduate Research Fellowships after previously cutting the number to 1,000 the year before. The rebound, announced after concerns that application timing and...

Revolution Medicines said its Phase 3 study of daraxonrasib in advanced pancreatic adenocarcinoma produced a median survival of 13.2 months versus 6.7 months with standard chemotherapy, delivering...

Kailera Therapeutics’ upsized IPO raised $625 million to fund global clinical trials across its pipeline of injectable and oral obesity drug candidates, extending investor focus on anti-obesity...

The Breakthrough Prize Foundation awarded Life Sciences prizes to pioneering teams behind landmark gene therapies, including work connected to a US-available retinal blindness treatment and...

Researchers reported an adenine base editing approach that corrects a cryptic splice mutation (IVS4+919, G>A) underlying cardiac-type Fabry disease in cells, according to a study published in Gene...

A Nature Communications study used wastewater-based epidemiology to detect the emergence of clinically significant and drug-resistant Candida auris strains in healthcare settings, mapping how...

Two separate policy updates pointed to a more enforcement-led FDA posture affecting both review and promotion of therapeutics. One report described an FDA budget proposal including policy “wish...

Scientists reported an AAV6.2 gene delivery system designed to drive localized expression of immunomodulatory cytokines in mouse lungs during inflammatory challenges, without detectable peripheral...

10x Genomics launched its Atera spatial platform at AACR 2026, positioning it as whole-transcriptome spatial biology at scale intended to reduce trade-offs seen in existing spatial tools. In...

UCB agreed to buy Neurona for up to $1.2 billion, aiming to add a potentially one-off seizure cell therapy to its primarily small-molecule portfolio. The transaction is intended to diversify...

Bruker announced leadership transitions within its BioSpin organization, with Falko Busse set to transition out of executive officer and BioSpin Group president roles around May 1, 2026. Jackson...

Revolution Medicines’ daraxonrasib, a KRAS-focused oral therapy, delivered a survival benefit in a Phase 3 pancreatic cancer readout highlighted by STAT+. In advanced pancreatic adenocarcinoma,...

Roche is laying additional groundwork for European regulators on its Duchenne muscular dystrophy gene therapy Elevidys (delandistrogene moxeparvovec). The company announced a further global Phase...